How much funding has Agios Pharmaceuticals raised?

Agios Pharmaceuticals has raised $241.0M in total funding, most recently a Series C round.

When was Agios Pharmaceuticals founded?

Agios Pharmaceuticals was founded in 2007.

Where is Agios Pharmaceuticals headquartered?

Agios Pharmaceuticals is headquartered in Cambridge, Massachusetts, United States.

What industry is Agios Pharmaceuticals in?

Agios Pharmaceuticals operates in Biotech, Drug Discovery, Healthcare, Life Sciences, Therapeutics.

How many employees does Agios Pharmaceuticals have?

Agios Pharmaceuticals has 501-1000 employees.

Agios Pharmaceuticals

Q: Who are Agios Pharmaceuticals's investors?

Agios Pharmaceuticals's investors include Public Investment Fund, Third Rock Ventures, ARCH Venture Partners, Flagship Pioneering.

IPO

Agios

Public · Cambridge, United States · Founded 2007 · $241.0M raised

Headquarters: Cambridge, Massachusetts
Employees: 501–1000
Founded: 2007
Business Model: B2B
Website: agios.com

Total Funding: $241.0M
Last Round: $78.0M Series CNov 2011
Rounds: 3
Type: Public

About

Agios is a commercial-stage biopharmaceutical company pioneering therapies for rare diseases through its leadership in cellular metabolism science. Its first FDA-approved therapy treats hemolytic anemia in adults with pyruvate kinase deficiency, and its lead pipeline candidate mitapivat is in late-stage trials for thalassemia and sickle cell disease. Agios also advances novel PK activators and multiple preclinical programs targeting rare hematologic conditions.

Summary

Agios Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $241.0M in total across 3 rounds, most recently a $78.0M Series C round in Nov 2011. Investors include Public Investment Fund, Third Rock Ventures and ARCH Venture Partners.

LinkedIn X (Twitter)